23.01.2025
The Ukrainian pharmaceutical market demonstrates one of the highest dynamics in Europe. Dozens of new drugs are registered in Ukraine every year, and pharmaceutical companies are actively competing for the attention of doctors and pharmacists.
In this environment, it is critical to identify key players in the healthcare industry. These experts, known as Key Opinion Leaders (KOLs) and Digital Opinion Leaders (DOLs), play a crucial role in shaping medical recommendations and influencing patient choice. Earlier on our website, we covered this topic in the article “KOLs/DOLs Rating: how pharmaceutical companies can understand healthcare professionals“.
To help pharmaceutical companies better understand the key persons in the Ukrainian healthcare sector, Proxima Research has created the KOLs/DOLs rating. This ranking is based on the regular PromoTest survey of promotional activity.
The study covers doctors and pharmacists in 28 cities of Ukraine. Respondents were asked who they consider to be the leading healthcare professionals whose opinion is important to them.
The results are presented in the form of a rating that shows the top opinion leaders in each medical specialty.
The project is being implemented in 3 countries:
The data covers 28 cities in Ukraine and 15 in Kazakhstan. This allows us to evaluate the influence of regional opinion leaders, providing a deeper analysis for pharmaceutical companies.
Opinion leaders, both traditional and digital, are an integral part of the modern pharmaceutical market. Their influence on shaping public opinion, adapting innovations and promoting brands cannot be overestimated. Effective cooperation with KOLs and DOLs is becoming a key to success for pharmaceutical companies.
We are pleased to announce that we have recently released updated KOLs/DOLs Healthcare Professionals Rating data, which allows pharmaceutical companies to obtain even more accurate and up-to-date analysis of the market situation.
For more information, please contact your Proxima Research manager.
By clicking the "Subscribe" button, you consent to the processing of personal data and the receipt of electronic messages about Proxima Research products and services, and you agree to our Terms of Use. Your data will be processed in accordance with our Privacy Policy. You can unsubscribe at any time.
or